MammaPrint | Agendia
Product description
The MammaPrint test is a 70-gene breast cancer recurrence assay that provides a risk of recurrence score. It is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines.